| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
50.00 ng |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
5.00 μg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
50.00 ng |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
5.00 μg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
50.00 ng |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on angiogenesis |
qRT-PCR |
5.00 μg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Animal weight |
125.00 mg/kg |
|
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Animal weight |
250.00 mg/kg |
|
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Animal weight |
500.00 mg/kg |
|
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Plasma concentration |
125.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Plasma concentration |
250.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Organism tollerance |
Plasma concentration |
500.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on glucose |
Glucose levels |
125.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on glucose |
Glucose levels |
250.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on glucose |
Glucose levels |
500.00 mg/kg |
plasma |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
p-STAT3 |
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
p-STAT3 |
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
p-STAT3 |
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on protein activity in diabetes |
Western Blot |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on vision loss |
Optokinetic Tracking- spatial frequency threshold |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on vision loss |
Optokinetic Tracking- spatial frequency threshold |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on vision loss |
Optokinetic Tracking- spatial frequency threshold |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on cataract severity |
Optokinetic Tracking- spatial frequency threshold |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on cataract severity |
Optokinetic Tracking- spatial frequency threshold |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on cataract severity |
Optokinetic Tracking- spatial frequency threshold |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
125.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
250.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| CLT-005 |
Influence on mediators of inflammation |
Rat Cytokine group I 23-Plex Assay |
500.00 mg/kg |
retina |
Rattus norvegicus |
BN |
|
|
| Gefitinib |
Inlfuence on cell viability in presence of DHA |
CCK8 assay |
10.00 µM |
NCI‑H1975 |
Homo sapiens |
|
|
|
| Gefitinib |
Inlfuence on cell viability |
CCK8 assay |
10.00 µM |
NCI‑H1975 |
Homo sapiens |
|
|
|
| Gefitinib |
Inlfuence on cell viability in presence of DHA |
TUNEL |
10.00 µM |
NCI‑H1975 |
Homo sapiens |
|
|
|
| Gefitinib |
Inlfuence on cell viability |
TUNEL |
10.00 µM |
NCI‑H1975 |
Homo sapiens |
|
|
|
| Gefitinib |
Inlfuence on cell cycle in presence of DHA |
Flow cytometry- annexin V binding and propidium iodide staining |
10.00 µM |
NCI‑H1975 |
Homo sapiens |
|
|
|
